Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.
Level 5 - mechanism / opinion, no new human data
Preclinical animal research (mouse parabiosis and protein administration)
PubMed 23663781 · doi:10.1016/j.cell.2013.04.015
What was done
Old mice were surgically joined to young mice using heterochronic parabiosis for 4 weeks to evaluate the effect of shared young circulation on age-related cardiac hypertrophy. Circulating factors that decline with age were identified using modified aptamer-based proteomics, highlighting GDF11. Old mice were subsequently treated with GDF11 to restore systemic levels to those found in young mice.
What was found
Exposure to young circulation for 4 weeks led to regression of cardiac hypertrophy in old mice, accompanied by reduced cardiomyocyte size and molecular remodeling. The abstract provides no specific numerical values, effect sizes, or statistical metrics. Exogenous restoration of GDF11 in old mice recapitulated the effects of parabiosis and reversed age-related cardiac hypertrophy.
Why it matters
The study identifies GDF11 as a circulating factor capable of reversing age-associated cardiac structural remodeling in mice, highlighting a potential systemic molecular target for age-related cardiac hypertrophy and diastolic heart failure.
Limits
Findings are entirely derived from mouse models, and relevance to human heart failure remains unproven. The abstract omits sample sizes, quantitative measurements, confidence intervals, dosing regimens, and long-term functional or safety endpoints.
Cited by
- supports Amy Wagers' laboratory found that GDF11 declines with age and that administering GDF11 to older mice replicates the rejuvenating benefits of young blood.